Evaluation of probiotics use for antibiotic-associated diarrhea in nursing homes

Probiotics use for antibiotic-associated diarrhea: a pragmatic participatory evaluation in nursing homes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN94786163

Enrollment

Registered

2020-02-03

Start date

2018-01-01

Completion date

Unknown

Last updated

2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotics-associated diarrhea Digestive System

Interventions

Data on the occurence (yes/no) of antibiotics-associated diarrhea is collected from residents taking either amoxicillin/clavulanic acid or ciprofloxacin. In three nursing home departm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Residents having used either amoxicillin/clavulanic acid or ciprofloxacin

Exclusion criteria

Exclusion criteria: 1. Not being able to swallow the probiotics 2. Not giving informed consent for using data

Design outcomes

Primary

Measure	Time frame
Incidence Antibiotics-associated diarrhea in the preceding 27 months, measured using patient records	—

Countries

Netherlands

Contacts

Public ContactHerman van Wietmarschen

h.vanwietmarschen@louisbolk.nl0343523860

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026